Michael A. Nead

Michael A. Nead, M.D., Ph.D., serves as Professor in the Department of Medicine at the University of Rochester School of Medicine and Dentistry, specializing in Pulmonary & Critical Care Medicine and Cancer. He is an active clinician within the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), providing patient care at the Pulmonary Clinic in Rochester, NY.

His academic foundation includes:

• M.D. from University of Rochester School of Medicine and Dentistry (1999)
• Fellowship in Pulmonary and Critical Care Medicine at Yale New Haven Hospital (2003-2006)
• Residency and Internship in Internal Medicine at University of Rochester Medical Center (1999-2002)

Dr. Nead's research bridges molecular biology and clinical pulmonary medicine, with current emphasis on lung cancer diagnostics through the Lung EpiCheck® clinical trial. His earlier work explored viral oncogenesis and gene regulation mechanisms, while recent efforts focus on interstitial lung disease characterization and non-invasive cancer screening methodologies. This trajectory demonstrates a deliberate shift from fundamental molecular research to translational applications addressing critical gaps in pulmonary diagnostics.

His publication history reveals a strategic evolution from 1980s-1990s investigations in virology, bacterial genetics, and environmental physiology toward contemporary clinical pulmonary research. Early work established expertise in transcriptional regulation and cellular transformation, while current publications prioritize lung cancer biomarker development and interstitial lung disease management, reflecting his commitment to converting basic science insights into clinical tools.

Notable recognitions include:

• T. Franklin Williams Award (2002)
• Milton S. Luria Award for clinical excellence (2000)
• Alpha Omega Alpha Honor Society membership (1999)
• Multiple undergraduate distinctions including Phi Beta Kappa and Presidential Scholar (1991)

As an educator, Dr. Nead mentors medical trainees while leading the Lung EpiCheck® trial investigating early-stage lung cancer detection in high-risk populations. His clinical practice demonstrates exceptional patient engagement, with consistent 4.9/5 star ratings across communication, diagnostic explanation, and treatment planning domains. The Pulmonary Clinic team collaborates with multidisciplinary researchers to advance lung cancer screening protocols and critical care interventions.